Opaleye Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Opaleye Management’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-490,000	Closed	-$1.17M	–	54
2019 Q3	$1.17M	Sell	490,000 -650,000	-57%	-$1.75M	0.42%	44
2019 Q2	$3.57M	Sell	1,140,000 -12,500	-1%	-$45.9K	1.09%	31
2019 Q1	$5.74M	Sell	1,152,500 -237,500	-17%	-$1.17M	1.59%	26
2018 Q4	$6.23M	Sell	1,390,000 -340,000	-20%	-$1.66M	2.32%	13
2018 Q3	$8.39M	Sell	1,730,000 -100,000	-5%	-$512K	2.13%	15
2018 Q2	$11M	Buy	1,830,000 +240,000	+15%	+$1.76M	2.84%	9
2018 Q1	$14.1M	Buy	1,590,000 +340,000	+27%	+$2.55M	4.02%	6
2017 Q4	$9.06M	Buy	1,250,000 +70,000	+6%	+$437K	2.9%	11
2017 Q3	$8.14M	Hold	1,180,000	–	–	2.88%	12
2017 Q2	$8.44M	Hold	1,180,000	–	–	3.52%	5
2017 Q1	$5.61M	Buy	1,180,000 +20,000	+2%	+$61.3K	2.79%	13
2016 Q4	$2.78M	Buy	+1,160,000	New	+$4.73M	1.64%	22

Other funds holding SBBP

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Opaleye Management's SBBP Position: Q4 2019 in Review

Opaleye Management sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2019, closing a stake of 490,000 shares — an estimated $1.17M sold.

Opaleye Management first reported a position in SBBP in Q4 2016 and held it in 12 quarters. The position peaked at $14.1M in Q1 2018. 58 funds tracked by Wall St. Rank hold SBBP as of Q4 2019.

Opaleye Management reported no remaining Strongbridge Biopharma plc. position as of Q4 2019 after selling out during the quarter.
Opaleye Management sold 490,000 Strongbridge Biopharma plc. shares in Q4 2019, an estimated $1.17M.
Opaleye Management first reported a position in Strongbridge Biopharma plc. in Q4 2016 and held it in 12 quarters.
Opaleye Management's Strongbridge Biopharma plc. position peaked at $14.1M in Q1 2018.
58 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2019.

Based on Opaleye Management's 13F filing for Q4 2019, filed 14 Feb 2020.